Abstract
It should be no surprise to pharmaceutical scientists and engineers that they work in an arena of complex multivariate phenomena which require costly and time-consuming efforts to monitor, understand, predict, and control. Indeed, it might be argued that an outcome of this small volume is to state the obvious. However, the approaches taken to maneuver in order to gain as much knowledge as possible if the systems involved to integrate them into larger product development and therapeutic objectives are dictated by the ability to acquire data reflecting the actual nature of the situation and interpret it appropriately.
Access this chapter
Tax calculation will be finalised at checkout
Purchases are for personal use only
References
Albert A (1960) Selective toxicity: the physico-chemical basis of therapy, 2nd edn. Australian National University/Wiley, Canberra/New York
Tipler FJ (1994) The physics of immortality. Anchor Books/Doubleday, New York
Author information
Authors and Affiliations
Corresponding author
Rights and permissions
Copyright information
© 2011 American Association of Pharmaceutical Scientists
About this chapter
Cite this chapter
Hickey, A.J., Smyth, H.D.C. (2011). Conclusion. In: Pharmaco-Complexity. Outlines in Pharmaceutical Sciences, vol 1. Springer, Boston, MA. https://doi.org/10.1007/978-1-4419-7856-1_7
Download citation
DOI: https://doi.org/10.1007/978-1-4419-7856-1_7
Published:
Publisher Name: Springer, Boston, MA
Print ISBN: 978-1-4419-7855-4
Online ISBN: 978-1-4419-7856-1
eBook Packages: Biomedical and Life SciencesBiomedical and Life Sciences (R0)